After a site change, the first comparison of the old tablets with the new ones often comes down to one number, f2.
f2 is the similarity factor for two dissolution profiles. It averages the squared difference between the curves at each time point and puts it on a scale where 100 means identical. A difference of 10% at every point gives 49.9, which is where the limit of 50 comes from.
FDA's 1997 guidance on dissolution testing of immediate-release solid oral dosage forms treats f2 values of 50 to 100 as showing that two curves are equivalent. The EMA bioequivalence guideline says an f2 between 50 and 100 suggests that the two profiles are similar.
The FDA text attaches conditions to the number: 12 units of each product, the same time points under exactly the same conditions, and only one measurement after 85% dissolution of both products.
A caution for the receiving site: an f2 of 52 passes with the curves about 9% apart on average, and that gap usually has a cause on the shop floor, such as granulation end point, press speed or coating.
Assay, impurities, uniformity and stability carry the rest of the comparison.
Topics




